Finance

Lists
TLSI:NASDAQ
TriSalus Life Sciences Inc
$4.25
-0.47%
(-0.020) 1D
$4.35
+2.35% (+0.100)
After hours
Closed: Oct 7, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TLSI...
Open
$4.21
High
$4.42
Low
$4.09
Mkt. cap
261.69M
Avg. vol.
361.58K
Volume
52.00
52-wk high
$7.95
52-wk low
$2.20
EPS
-$1.29
Beta
0.47
Shares outstanding
61.58M
No. of employees
102
Open
$4.21
High
$4.42
Low
$4.09
Mkt. cap
261.69M
Avg. vol.
361.58K
Volume
52.00
52-wk high
$7.95
52-wk low
$2.20
EPS
-$1.29
Beta
0.47
Shares outstanding
61.58M
No. of employees
102
News stories
From web sources and news partners
About TriSalus Life Sciences Inc
CEO-
Employees102
Founded2009
HeadquartersWestminster, Colorado, United States
SectorBiotechnology
Websitetrisaluslifesci.com
Analyst ratings
Based on 5 analysts giving stock ratings to TLSI in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for TLSI in the last 3 months.
Highest
Current $4.25
$14.00 (+229.41%)
Average
$10.40 (+144.71%)
Lowest
$7.00 (+64.71%)
Analyst
Recommendation
Action
Price target
Projected
Date
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
$12.00
+182.4%
10/01/2026
Frank Takkinen
Lake Street
Buy
Reiterated
$8.00
+88.2%
09/23/2026
William Plovanic
Canaccord Genuity
Buy
Maintained
$7.00
+64.7%
09/23/2026
Jason McCarthy
Maxim Group
Buy
Reiterated
$14.00
+229.4%
08/10/2026
Justin Walsh
JonesTrading
Buy
Reiterated
$11.00
+158.8%
08/10/2026
Carl Byrnes
Northland Securities
Buy
Reiterated
$8.00
+88.2%
03/23/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
11.57M
13.20M
8.90M
11.41M
Cost of goods sold
1.91M
1.76M
1.23M
1.51M
Cost of revenue
1.91M
1.76M
1.23M
1.51M
Research and development expenses
5.18M
2.57M
3.22M
3.14M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13.50M
12.14M
12.86M
16.58M
Operating expense
18.67M
14.71M
16.08M
19.71M
Total operating expenses
20.58M
16.48M
17.31M
21.22M
Operating income
-9.01M
-3.27M
-8.41M
-9.81M
Other non operating income
-3.03M
-60.00K
3.82M
2.66M
EBT including unusual items
-10.81M
-9.75M
1.54M
-9.18M
EBT excluding unusual items
-13.33M
-4.61M
-5.86M
-8.19M
Income tax expense
5.00K
-
4.00K
4.00K
Effective tax rate
-0.05%
-
0.26%
-0.04%
Other operating expenses
-
-
-
-
Net income
-10.81M
-9.75M
1.54M
-9.19M
Net profit margin
-93.47%
-73.86%
17.29%
-80.54%
Earnings per share
-0.87
-0.05
-0.14
-
Interest and investment income
170.00K
177.00K
164.00K
457.00K
Interest expense
-1.46M
-1.45M
-1.44M
-1.49M
Net interest expenses
-1.29M
-1.28M
-1.27M
-1.03M
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.85M
-3.14M
-8.28M
-9.68M
Gain or loss from assets sale
-
3.00K
1.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps